DF/Net Provides Data Management for the World’s First FDA-Approved HIV Prevention Drug


DF/Net was chosen by the University of Washington and Gladstone Institutes to be the data management center for the iPrEx and the Partners PrEP studies, two pivotal Phase III clinical trials that formed the basis of the FDA submission of Truvada.  …Read  More ›

Seattle BioMed Launches Groundbreaking Anti-Malaria Vaccine Trial

January 2015. After a decade of research and grants from the Gates Foundation and the Department of Defense, Seattle BioMed’s novel anti-malarial vaccine strategy will be put to the test in an effort to combat a disease that is still responsible for half a deaths per year around the world. Project leader Stefan Kappe and his team have used genetic engineering to remove mosquito genes crucial to the parasite’s development. …Read More ›